Related Experiment Video

Updated: Sep 29, 2025

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

26.8K

Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations

Dawei Chen1, Tao Wang2, Xin Ye1

  • 1Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, Guangdong, China.

Stem Cell Research
|March 19, 2022
PubMed

Insights

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a common condition. Researchers created a patient-specific induced pluripotent stem cell (iPSC) line to study anti-CD36 FNAIT and develop new therapies.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Genetics

Background:

  • Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a significant clinical concern.
  • Anti-CD36 isoantibodies are a common cause of FNAIT.
  • Type I CD36 deficiency is prevalent in Eastern Asian populations.

Purpose of the Study:

  • To generate a patient-specific induced pluripotent stem cell (iPSC) line for studying anti-CD36 mediated FNAIT.
  • To investigate potential therapeutic strategies for FNAIT using hiPSC models.

Main Methods:

  • Generated a hiPSC line from peripheral blood mononuclear cells of a patient with a CD36 gene mutation (329-330delAC).
  • Characterized the hiPSC line for pluripotency markers and differentiation potential.
  • Confirmed normal karyotype and retention of the patient-specific mutation.

Main Results:

  • Successfully generated a hiPSC line carrying the specific CD36 mutation.
  • The hiPSC line expressed key pluripotency markers.
  • Spontaneous differentiation confirmed the potential to form derivatives of all three germ layers.
  • The hiPSC line maintained a normal karyotype.

Conclusions:

  • Patient-specific hiPSCs are valuable tools for understanding anti-CD36 mediated FNAIT.
  • This generated hiPSC line provides a platform for future research into FNAIT pathogenesis and therapeutics.
  • The study highlights the utility of iPSC technology in rare genetic disease modeling.

More Related Videos

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

10.9K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.3K

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K